0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valsartan Capsules Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-28K18297
Home | Market Reports
Global Valsartan Capsules Market Research Report 2024
BUY CHAPTERS

Global Valsartan Capsules Market Research Report 2026

Code: QYRE-Auto-28K18297
Report
2026-02-03
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Valsartan Capsules Market

The global Valsartan Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Valsartan Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Valsartan capsules are a type of medication belonging to the class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which narrows blood vessels. By blocking this hormone, valsartan helps to relax blood vessels, lower blood pressure, and reduce the workload on the heart.
The North American market for Valsartan Capsules is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Valsartan Capsules is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Valsartan Capsules include Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Valsartan Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Valsartan Capsules. The Valsartan Capsules market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Valsartan Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Valsartan Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Valsartan Capsules Market Report

Report Metric Details
Report Name Valsartan Capsules Market
Segment by Type
  • 40 Mg
  • 80 Mg
  • 160 Mg
  • Others
by Application
  • Treatment of Hypertension
  • Treatment of Heart Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Valsartan Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Valsartan Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Valsartan Capsules Market report?

Ans: The main players in the Valsartan Capsules Market are Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical

What are the Application segmentation covered in the Valsartan Capsules Market report?

Ans: The Applications covered in the Valsartan Capsules Market report are Treatment of Hypertension, Treatment of Heart Disease, Others

What are the Type segmentation covered in the Valsartan Capsules Market report?

Ans: The Types covered in the Valsartan Capsules Market report are 40 Mg, 80 Mg, 160 Mg, Others

1 Valsartan Capsules Market Overview
1.1 Product Definition
1.2 Valsartan Capsules by Type
1.2.1 Global Valsartan Capsules Market Value by Type: 2025 vs 2032
1.2.2 40 Mg
1.2.3 80 Mg
1.2.4 160 Mg
1.2.5 Others
1.3 Valsartan Capsules by Application
1.3.1 Global Valsartan Capsules Market Value by Application: 2025 vs 2032
1.3.2 Treatment of Hypertension
1.3.3 Treatment of Heart Disease
1.3.4 Others
1.4 Global Valsartan Capsules Market Size Estimates and Forecasts
1.4.1 Global Valsartan Capsules Revenue 2021–2032
1.4.2 Global Valsartan Capsules Sales 2021–2032
1.4.3 Global Valsartan Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Valsartan Capsules Market Competition by Manufacturers
2.1 Global Valsartan Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Valsartan Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Valsartan Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Valsartan Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Valsartan Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Valsartan Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Valsartan Capsules, Date of Entry into the Industry
2.8 Global Valsartan Capsules Market Competitive Situation and Trends
2.8.1 Global Valsartan Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Valsartan Capsules Players Market Share by Revenue
2.8.3 Global Valsartan Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valsartan Capsules Market Scenario by Region
3.1 Global Valsartan Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Valsartan Capsules Sales by Region: 2021–2032
3.2.1 Global Valsartan Capsules Sales by Region: 2021–2026
3.2.2 Global Valsartan Capsules Sales by Region: 2027–2032
3.3 Global Valsartan Capsules Revenue by Region: 2021–2032
3.3.1 Global Valsartan Capsules Revenue by Region: 2021–2026
3.3.2 Global Valsartan Capsules Revenue by Region: 2027–2032
3.4 North America Valsartan Capsules Market Facts & Figures by Country
3.4.1 North America Valsartan Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Valsartan Capsules Sales by Country (2021–2032)
3.4.3 North America Valsartan Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valsartan Capsules Market Facts & Figures by Country
3.5.1 Europe Valsartan Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Valsartan Capsules Sales by Country (2021–2032)
3.5.3 Europe Valsartan Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Valsartan Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Valsartan Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Valsartan Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Valsartan Capsules Market Facts & Figures by Country
3.7.1 Latin America Valsartan Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Valsartan Capsules Sales by Country (2021–2032)
3.7.3 Latin America Valsartan Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Valsartan Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Valsartan Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Valsartan Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan Capsules Sales by Type (2021–2032)
4.1.1 Global Valsartan Capsules Sales by Type (2021–2026)
4.1.2 Global Valsartan Capsules Sales by Type (2027–2032)
4.1.3 Global Valsartan Capsules Sales Market Share by Type (2021–2032)
4.2 Global Valsartan Capsules Revenue by Type (2021–2032)
4.2.1 Global Valsartan Capsules Revenue by Type (2021–2026)
4.2.2 Global Valsartan Capsules Revenue by Type (2027–2032)
4.2.3 Global Valsartan Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Valsartan Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Valsartan Capsules Sales by Application (2021–2032)
5.1.1 Global Valsartan Capsules Sales by Application (2021–2026)
5.1.2 Global Valsartan Capsules Sales by Application (2027–2032)
5.1.3 Global Valsartan Capsules Sales Market Share by Application (2021–2032)
5.2 Global Valsartan Capsules Revenue by Application (2021–2032)
5.2.1 Global Valsartan Capsules Revenue by Application (2021–2026)
5.2.2 Global Valsartan Capsules Revenue by Application (2027–2032)
5.2.3 Global Valsartan Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Valsartan Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Lepu Medical
6.1.1 Lepu Medical Company Information
6.1.2 Lepu Medical Description and Business Overview
6.1.3 Lepu Medical Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Lepu Medical Valsartan Capsules Product Portfolio
6.1.5 Lepu Medical Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novartis Valsartan Capsules Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Valsartan Capsules Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Company Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Company Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Dynemed
6.7.1 Dynemed Company Information
6.7.2 Dynemed Description and Business Overview
6.7.3 Dynemed Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Dynemed Valsartan Capsules Product Portfolio
6.7.5 Dynemed Recent Developments/Updates
6.8 Conquer
6.8.1 Conquer Company Information
6.8.2 Conquer Description and Business Overview
6.8.3 Conquer Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Conquer Valsartan Capsules Product Portfolio
6.8.5 Conquer Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Company Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan Capsules Industry Chain Analysis
7.2 Valsartan Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan Capsules Production Mode & Process Analysis
7.4 Valsartan Capsules Sales and Marketing
7.4.1 Valsartan Capsules Sales Channels
7.4.2 Valsartan Capsules Distributors
7.5 Valsartan Capsules Customer Analysis
8 Valsartan Capsules Market Dynamics
8.1 Valsartan Capsules Industry Trends
8.2 Valsartan Capsules Market Drivers
8.3 Valsartan Capsules Market Challenges
8.4 Valsartan Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Valsartan Capsules Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Valsartan Capsules Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Valsartan Capsules Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Valsartan Capsules Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Valsartan Capsules Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Valsartan Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Valsartan Capsules Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Valsartan Capsules Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Valsartan Capsules, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Valsartan Capsules, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Valsartan Capsules, Product Types and Applications
 Table 12. Global Key Manufacturers of Valsartan Capsules, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Valsartan Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Valsartan Capsules Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Valsartan Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Valsartan Capsules Sales by Region (K Dose), 2021–2026
 Table 18. Global Valsartan Capsules Sales Market Share by Region (2021–2026)
 Table 19. Global Valsartan Capsules Sales by Region (K Dose), 2027–2032
 Table 20. Global Valsartan Capsules Sales Market Share by Region (2027–2032)
 Table 21. Global Valsartan Capsules Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Valsartan Capsules Revenue Market Share by Region (2021–2026)
 Table 23. Global Valsartan Capsules Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Valsartan Capsules Revenue Market Share by Region (2027–2032)
 Table 25. North America Valsartan Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Valsartan Capsules Sales by Country (K Dose), 2021–2026
 Table 27. North America Valsartan Capsules Sales by Country (K Dose), 2027–2032
 Table 28. North America Valsartan Capsules Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Valsartan Capsules Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Valsartan Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Valsartan Capsules Sales by Country (K Dose), 2021–2026
 Table 32. Europe Valsartan Capsules Sales by Country (K Dose), 2027–2032
 Table 33. Europe Valsartan Capsules Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Valsartan Capsules Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Valsartan Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Valsartan Capsules Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific Valsartan Capsules Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific Valsartan Capsules Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Valsartan Capsules Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Valsartan Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Valsartan Capsules Sales by Country (K Dose), 2021–2026
 Table 42. Latin America Valsartan Capsules Sales by Country (K Dose), 2027–2032
 Table 43. Latin America Valsartan Capsules Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Valsartan Capsules Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Valsartan Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Valsartan Capsules Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa Valsartan Capsules Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa Valsartan Capsules Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Valsartan Capsules Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Valsartan Capsules Sales (K Dose) by Type (2021–2026)
 Table 51. Global Valsartan Capsules Sales (K Dose) by Type (2027–2032)
 Table 52. Global Valsartan Capsules Sales Market Share by Type (2021–2026)
 Table 53. Global Valsartan Capsules Sales Market Share by Type (2027–2032)
 Table 54. Global Valsartan Capsules Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Valsartan Capsules Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Valsartan Capsules Revenue Market Share by Type (2021–2026)
 Table 57. Global Valsartan Capsules Revenue Market Share by Type (2027–2032)
 Table 58. Global Valsartan Capsules Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Valsartan Capsules Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Valsartan Capsules Sales (K Dose) by Application (2021–2026)
 Table 61. Global Valsartan Capsules Sales (K Dose) by Application (2027–2032)
 Table 62. Global Valsartan Capsules Sales Market Share by Application (2021–2026)
 Table 63. Global Valsartan Capsules Sales Market Share by Application (2027–2032)
 Table 64. Global Valsartan Capsules Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Valsartan Capsules Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Valsartan Capsules Revenue Market Share by Application (2021–2026)
 Table 67. Global Valsartan Capsules Revenue Market Share by Application (2027–2032)
 Table 68. Global Valsartan Capsules Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Valsartan Capsules Price (US$/Dose) by Application (2027–2032)
 Table 70. Lepu Medical Company Information
 Table 71. Lepu Medical Description and Business Overview
 Table 72. Lepu Medical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Lepu Medical Valsartan Capsules Product
 Table 74. Lepu Medical Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Novartis Valsartan Capsules Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Mylan Valsartan Capsules Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Teva Pharmaceutical Industries Company Information
 Table 86. Teva Pharmaceutical Industries Description and Business Overview
 Table 87. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. Teva Pharmaceutical Industries Valsartan Capsules Product
 Table 89. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 90. Torrent Pharmaceuticals Company Information
 Table 91. Torrent Pharmaceuticals Description and Business Overview
 Table 92. Torrent Pharmaceuticals Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. Torrent Pharmaceuticals Valsartan Capsules Product
 Table 94. Torrent Pharmaceuticals Recent Developments/Updates
 Table 95. Sun Pharmaceutical Company Information
 Table 96. Sun Pharmaceutical Description and Business Overview
 Table 97. Sun Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. Sun Pharmaceutical Valsartan Capsules Product
 Table 99. Sun Pharmaceutical Recent Developments/Updates
 Table 100. Dynemed Company Information
 Table 101. Dynemed Description and Business Overview
 Table 102. Dynemed Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. Dynemed Valsartan Capsules Product
 Table 104. Dynemed Recent Developments/Updates
 Table 105. Conquer Company Information
 Table 106. Conquer Description and Business Overview
 Table 107. Conquer Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. Conquer Valsartan Capsules Product
 Table 109. Conquer Recent Developments/Updates
 Table 110. Cisen Pharmaceutical Company Information
 Table 111. Cisen Pharmaceutical Description and Business Overview
 Table 112. Cisen Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Cisen Pharmaceutical Valsartan Capsules Product
 Table 114. Cisen Pharmaceutical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Valsartan Capsules Distributors List
 Table 118. Valsartan Capsules Customers List
 Table 119. Valsartan Capsules Market Trends
 Table 120. Valsartan Capsules Market Drivers
 Table 121. Valsartan Capsules Market Challenges
 Table 122. Valsartan Capsules Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Valsartan Capsules
 Figure 2. Global Valsartan Capsules Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Valsartan Capsules Market Share by Type: 2025 & 2032
 Figure 4. 40 Mg Product Picture
 Figure 5. 80 Mg Product Picture
 Figure 6. 160 Mg Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Valsartan Capsules Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Valsartan Capsules Market Share by Application: 2025 & 2032
 Figure 10. Treatment of Hypertension
 Figure 11. Treatment of Heart Disease
 Figure 12. Others
 Figure 13. Global Valsartan Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Valsartan Capsules Market Size (US$ Million), 2021–2032
 Figure 15. Global Valsartan Capsules Sales (K Dose), 2021–2032
 Figure 16. Global Valsartan Capsules Average Price (US$/Dose), 2021–2032
 Figure 17. Valsartan Capsules Report Years Considered
 Figure 18. Valsartan Capsules Sales Share by Manufacturers in 2025
 Figure 19. Global Valsartan Capsules Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Valsartan Capsules Players: Market Share by Revenue in Valsartan Capsules in 2025
 Figure 21. Valsartan Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Valsartan Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Valsartan Capsules Sales Market Share by Country (2021–2032)
 Figure 24. North America Valsartan Capsules Revenue Market Share by Country (2021–2032)
 Figure 25. United States Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Valsartan Capsules Sales Market Share by Country (2021–2032)
 Figure 28. Europe Valsartan Capsules Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Valsartan Capsules Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Valsartan Capsules Revenue Market Share by Region (2021–2032)
 Figure 36. China Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Valsartan Capsules Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Valsartan Capsules Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Valsartan Capsules Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Valsartan Capsules Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Valsartan Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Valsartan Capsules by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Valsartan Capsules by Type (2021–2032)
 Figure 56. Global Valsartan Capsules Price (US$/Dose) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Valsartan Capsules by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Valsartan Capsules by Application (2021–2032)
 Figure 59. Global Valsartan Capsules Price (US$/Dose) by Application (2021–2032)
 Figure 60. Valsartan Capsules Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture